LabCompass

Philip Diaz

Medicine · The Ohio State University

Established · publishing since 1987

Publications

51

Citations

1,645

Est. group size

~5

Recurring co-author estimate

Active years

40

Publishing since 1987

Research summary
AI-generated

Philip Diaz's research focuses on chronic lung diseases, especially Chronic Obstructive Pulmonary Disease (COPD), and related complications such as oxygen therapy adherence, hospitalization risk, and cardiac issues like atrial fibrillation. His work also touches on cystic fibrosis, tuberculosis in HIV patients, and other respiratory conditions, often through clinical trials and observational studies. This research aims to improve treatment strategies and understand disease progression in patients with chronic respiratory and immune-related conditions.

Chronic Obstructive Pulmonary Disease (COPD)Respiratory therapy and oxygen treatmentPulmonary disease complications (e.g., hemoptysis, cachexia)HIV and infection-related lung diseaseCystic fibrosis and airway disorders

Publication output has been relatively steady but modest over the last decade, averaging about 2 papers per year in the last 5 years with some fluctuation.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.0/year recently
2017: 2 publications172018: 4 publications4182019: 3 publications192020: 1 publication202021: 1 publication212022: 3 publications222023: 1 publication232024: 2 publications242025: 3 publications252026: 1 publication26
Recent publications
Publishes in
  • CHEST Journal×3
  • Cell Host & Microbe×1
  • The Annals of Thoracic Surgery×1
  • Annals of the American Thoracic Society×1
  • The Lancet HIV×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile